Skip to content

Drug interactions

Etravirine + Glimepiride-pioglitazone

Severity: Minor

Etravirine and Glimepiride-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etravirine is a modest inducer of CYP3A4 and may lower pioglitazone exposure, since pioglitazone is metabolized mainly by CYP2C8 with some CYP3A4 contribution. The effect on glycemic control is expected to be small.

What this interaction means in plain words

Etravirine and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Etravirine belongs to Anti Virals; Glimepiride-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Etravirine induces CYP3A4 (and CYP2C9/2C19 effects), potentially increasing pioglitazone clearance.

What to do

Monitor glucose control and HbA1c after starting etravirine. Adjust the pioglitazone dose if control deteriorates.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etravirine and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etravirine with Glimepiride-pioglitazone?

MediHelp rates the interaction as minor. Etravirine and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Etravirine is a modest inducer of CYP3A4 and may lower pioglitazone exposure, since pioglitazone is metabolized mainly by CYP2C8 with some CYP3A4 contribution. The effect on glycemic control is expected to be small.

How serious is the interaction between Etravirine and Glimepiride-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose control and HbA1c after starting etravirine. Adjust the pioglitazone dose if control deteriorates.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in